<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">actabiomedica</journal-id><journal-title-group><journal-title xml:lang="ru">Acta Biomedica Scientifica</journal-title><trans-title-group xml:lang="en"><trans-title>Acta Biomedica Scientifica</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2541-9420</issn><issn pub-type="epub">2587-9596</issn><publisher><publisher-name>Scientific Centre for Family Health and Human Reproduction Problems</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.29413/ABS.2023-8.6.13</article-id><article-id custom-type="elpub" pub-id-type="custom">actabiomedica-4500</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>МОРФОЛОГИЯ, ФИЗИОЛОГИЯ И ПАТОФИЗИОЛОГИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>MORPHOLOGY, PHYSIOLOGY AND PATHOPHYSIOLOGY</subject></subj-group></article-categories><title-group><article-title>Фармакологическая блокада каннабиноидных рецепторов II типа при трансплантации мезенхимальных стволовых клеток в модели периферической нейропатической боли</article-title><trans-title-group xml:lang="en"><trans-title>Pharmacological blockade of cannabinoid type II receptors and mesenchymal stem cell transplantation in a model of peripheral neuropathic pain</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9407-9295</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ерофеева</surname><given-names>А.-М. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Yerofeyeva</surname><given-names>A.-M. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ерофеева Анна-Мария Вадимовна – аспирант, младший научный сотрудник лаборатории биологического моделирования </p><p>220072, г. Минск, ул. Академическая, 28</p></bio><bio xml:lang="en"><p>Anna-Maria V. Yerofeyeva – Postgraduate, Junior Research Officer at the Laboratory of Biological Modeling </p><p>Akademicheskaya str. 28, Minsk 220072</p></bio><email xlink:type="simple">amyerofeyeva@zoho.eu</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5499-5950</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Пинчук</surname><given-names>С. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Pinchuk</surname><given-names>S. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Пинчук Сергей Владимирович – кандидат биологических наук, ведущий научный сотрудник лаборатории молекулярной биологии клетки </p><p>220072, г. Минск, ул. Академическая, 27</p></bio><bio xml:lang="en"><p>Sergei V. Pinchuk – Cand. Sc. (Biol.), Leading Research Officer at the Laboratory of Molecular Cell Biology </p><p>Akademicheskaya str. 28, Minsk 220072</p></bio><email xlink:type="simple">pinchuksv@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5960-3656</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Рябцева</surname><given-names>С. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Rjabceva</surname><given-names>S. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Рябцева Светлана Николаевна – кандидат медицинских наук, заведующий лабораторией «Центр электронной и световой микроскопии» </p><p>220072, г. Минск, ул. Академическая, 28</p></bio><bio xml:lang="en"><p>Svetlana  N. Rjabceva – Cand.  Sc. (Med.), Head of the Laboratory «Center of Electron and Light Microscopy» </p><p>Akademicheskaya str. 28, Minsk 220072</p></bio><email xlink:type="simple">ryabceva@physiology.by</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5053-6602</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Молчанова</surname><given-names>А. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Molchanova</surname><given-names>A. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Молчанова Алла Юрьевна – кандидат биологических наук, ведущий научный сотрудник лаборатории биологического моделирования </p><p>220072, г. Минск, ул. Академическая, 28</p></bio><bio xml:lang="en"><p>Alla  Yu. Molchanova – Cand.  Sc. (Biol.), Leading Research Officer at the Laboratory of Biological Modeling </p><p>Akademicheskaya str. 28, Minsk 220072</p></bio><email xlink:type="simple">kjordknits@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ГНУ «Институт физиологии НАН Беларуси»</institution></aff><aff xml:lang="en"><institution>Institute of Physiology, National Academy of Sciences of Belarus</institution></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ГНУ «Институт биофизики и клеточной инженерии НАН Беларуси»</institution></aff><aff xml:lang="en"><institution>Institute of Biophysics and Cell Engineering, National Academy of Sciences of Belarus</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>15</day><month>01</month><year>2024</year></pub-date><volume>8</volume><issue>6</issue><fpage>141</fpage><lpage>152</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Ерофеева А.В., Пинчук С.В., Рябцева С.Н., Молчанова А.Ю., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Ерофеева А.В., Пинчук С.В., Рябцева С.Н., Молчанова А.Ю.</copyright-holder><copyright-holder xml:lang="en">Yerofeyeva A.V., Pinchuk S.V., Rjabceva S.N., Molchanova A.Y.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.actabiomedica.ru/jour/article/view/4500">https://www.actabiomedica.ru/jour/article/view/4500</self-uri><abstract><sec><title>Цель исследования</title><p>Цель исследования. Оценить антиноцицептивный и репаративный эффекты мезенхимальных стволовых клеток жировой ткани (МСК  ЖТ) на  фоне фармакологической блокады каннабиноидных рецепторов CB2 в модели периферической нейропатической боли.</p></sec><sec><title>Материал и методы</title><p>Материал и методы. У 40 крыс-самцов Wistar осуществили моделирование периферической нейропатии (НП) путём иссечения участка седалищного нерва. На 7-е сутки исследования проведена трансплантация МСК  ЖТ (1 × 106 клеток/кг) в область повреждения седалищного нерва без дополнительных воздействий, а также после локального введения антагониста СВ2-рецептора АМ630 и предварительной инкубации с АМ630. В течение 90 суток регистрировали ноцицептивную чувствительность и анализировали походку крыс с  помощью CatWalk  XT (Noldus, Нидерланды). На 21-е и 90-е сутки проведена оценка гистоструктуры дистального сегмента седалищного нерва после аксотомии.</p></sec><sec><title>Результаты</title><p>Результаты. Фармакологическая блокада СВ2-рецепторов как на мембранах МСК  ЖТ, так  и  в  мягких тканях, окружающих место повреждения седалищного нерва, приводила к снижению порога и латентного периода ноцицептивной реакции с 28-х суток исследования по сравнению с группой крыс с НП и группой животных после трансплантации только МСК ЖТ. После локального введения АМ630 перед трансплантацией МСК ЖТ отмечены ухудшение параметров походки, вызванные НП, и увеличение доли повреждённых нервных волокон в дистальном сегменте седалищного нерва. Трансплантация МСК, преинкубированных с АМ630, не оказывала существенного влияния на скорость восстановления параметров походки, к 90-м суткам исследования сопровождалась снижением числа повреждённых нервных волокон.</p></sec><sec><title>Заключение</title><p>Заключение. Блокада СВ2-рецепторов как на мембранах МСК, так в зоне повреждения периферического нерва сопровождается снижением антиноцицептивного эффекта МСК при их локальной трансплантации и подавляет репаративное действие МСК.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Objective</title><p>Objective. To evaluate the anti-nociceptive and reparative effects of adipose-derived mesenchymal stem cells (ADMSCs) under the pharmacological blockade of cannabinoid CB2 receptors in a model of peripheral neuropathic pain.</p></sec><sec><title>Material and methods</title><p>Material and methods. In 40 male Wistar rats, modeling of peripheral neuropathy (NP) was performed by excising a sciatic nerve. On day 7 of the study, ADMSCs (1 × 106 cells/kg) were transplanted into the area of sciatic nerve injury without additional influences or after administration of the CB2 receptor antagonist AM630, as well as after incubation with AM630. Within 90  days, nociceptive sensitivity was studied, as well as a detailed analysis of gait using CatWalk XT (Noldus, Netherlands). On day 21 and day 90, histostructure of the distal segment of the sciatic nerve was assessed.</p></sec><sec><title>Results</title><p>Results. Pharmacological blockade of CB2 receptors both on the ADMSCs and in the soft tissues surrounding the site of sciatic nerve injury led to a decrease in withdrawal threshold and withdrawal latency from day 28 of the study compared with the group of rats with NP and transplantation of ADMSCs only. Local injection of AM630 before transplantation of ADMSCs contributed to the development of  NP-induced gait disturbances and increase of the number of damaged nerve fibers in the distal segment of sciatic nerve. Transplantation of ADMSCs pretreated with  AM630 did not significantly affect the rate of recovery of gait parameters, and decreased the number of damaged nerve fibers by day 90 of study.</p></sec><sec><title>Conclusion</title><p>Conclusion. Blockade of CB2 receptors, both on the membranes of MSCs and in the area of damage to the peripheral nerve, has a negative effect on the development of the anti-nociceptive and reparative effects of MSCs.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>мезенхимальные стволовые клетки</kwd><kwd>нейропатическая боль</kwd><kwd>седалищный нерв</kwd><kwd>каннабиноидные рецепторы</kwd><kwd>фармакологическая блокада СВ2-рецепторов</kwd></kwd-group><kwd-group xml:lang="en"><kwd>mesenchymal stem cells</kwd><kwd>neuropathic pain</kwd><kwd>sciatic nerve</kwd><kwd>cannabinoid receptors</kwd><kwd>pharmacological blockade of CB2 receptors</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Исследование проведено на базе ГНУ «Институт физиологии НАН Беларуси» в рамках диссертационной работы за счёт средств республиканского бюджета.</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Scholz J, Finnerup NB, Attal N, Aziz Q, Baron R, Bennett MI, et al. The IASP classification of chronic pain for ICD-11: Chronic neuropathic pain. Pain. 2019; 160(1): 53-59. doi: 10.1097/j.pain.0000000000001365</mixed-citation><mixed-citation xml:lang="en">Scholz J, Finnerup NB, Attal N, Aziz Q, Baron R, Bennett MI, et al. The IASP classification of chronic pain for ICD-11: Chronic neuropathic pain. Pain. 2019; 160(1): 53-59. doi: 10.1097/j.pain.0000000000001365</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Bouhassira D. Neuropathic pain: Definition, assessment and epidemiology. Rev Neurol (Paris). 2019; 175(1-2): 16-25. doi: 10.1016/j.neurol.2018.09.016</mixed-citation><mixed-citation xml:lang="en">Bouhassira D. Neuropathic pain: Definition, assessment and epidemiology. Rev Neurol (Paris). 2019; 175(1-2): 16-25. doi: 10.1016/j.neurol.2018.09.016</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Colloca L, Ludman T, Bouhassira D, Baron R, Dickenson AH, Yarnitsky D, et al. Neuropathic pain. Nat Rev Dis Primers. 2017; 3: 17002. doi: 10.1038/nrdp.2017.2</mixed-citation><mixed-citation xml:lang="en">Colloca L, Ludman T, Bouhassira D, Baron R, Dickenson AH, Yarnitsky D, et al. Neuropathic pain. Nat Rev Dis Primers. 2017; 3: 17002. doi: 10.1038/nrdp.2017.2</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Cavalli E, Mammana S, Nicoletti F, Bramanti P, Mazzon E. The neuropathic pain: An overview of the current treatment and future therapeutic approaches. Int J Immunopathol Pharmacol. 2019; 33: 2058738419838383. doi: 10.1177/2058738419838383</mixed-citation><mixed-citation xml:lang="en">Cavalli E, Mammana S, Nicoletti F, Bramanti P, Mazzon E. The neuropathic pain: An overview of the current treatment and future therapeutic approaches. Int J Immunopathol Pharmacol. 2019; 33: 2058738419838383. doi: 10.1177/2058738419838383</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Zhou Y, Yamamoto Y, Xiao Z, Ochiya T. The immunomodulatory functions of mesenchymal stromal/stem cells mediated via paracrine activity. J Clin Med. 2019; 8(7): 1025. doi: 10.3390/jcm8071025</mixed-citation><mixed-citation xml:lang="en">Zhou Y, Yamamoto Y, Xiao Z, Ochiya T. The immunomodulatory functions of mesenchymal stromal/stem cells mediated via paracrine activity. J Clin Med. 2019; 8(7): 1025. doi: 10.3390/jcm8071025</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Ерофеева А.-М.В., Молчанова А.Ю. Влияние трансплантации аллогенных мезенхимальных стволовых клеток жировой ткани на ноцицептивные реакции и параметры походки крыс с экспериментальной периферической нейропатией. Весці Нацыянальнай акадэміі навук Беларусі. Серыя медыцынскіх навук. 2022; 19(4): 404-412. doi: 10.29235/1814-6023-2022-19-4-404-412</mixed-citation><mixed-citation xml:lang="en">Yerofeyeva AMV, Molchanova AYu. Impact of adipose-derived allogeneic mesenchymal stem cell transplantation on nociceptive reactions and gait parameters in rats with experimental peripheral neuropathy. Proceedings of the National Academy of Sciences of Belarus, Medical series. 2022; 19(4): 404-412. (In Russ.). doi: 10.29235/1814-6023-2022-19-4-404-412</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Ерофеева А.-М.В. Влияние фармакологической блокады каннабиноидных рецепторов 1 типа на эффективность трансплантации мезенхимальных стволовых клеток при экспериментальной периферической нейропатии. Вестник ВГМУ. 2022; 21(6): 46-57. doi: 10.22263/2312-4156.2022.6.47</mixed-citation><mixed-citation xml:lang="en">Erofeeva AMV. The impact of pharmacological blocking of type 1 cannabinoid receptors on the effectiveness of mesenchymal stem cell transplantation in experimental peripheral neuropathy. Vitebsk Medical Journal. 2022; 21(6): 46-57. (In Russ.). doi: 10.22263/2312-4156.2022.6.47</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Guo W, Chu YX, Imai S, Yang JL, Zou S, Mohammad Z, et al. Further observations on the behavioral and neural effects of bone marrow stromal cells in rodent pain models. Mol Pain. 2016; 12: 1744806916658043. doi: 10.1177/1744806916658043</mixed-citation><mixed-citation xml:lang="en">Guo W, Chu YX, Imai S, Yang JL, Zou S, Mohammad Z, et al. Further observations on the behavioral and neural effects of bone marrow stromal cells in rodent pain models. Mol Pain. 2016; 12: 1744806916658043. doi: 10.1177/1744806916658043</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Guo W, Wang H, Zou S, Gu M, Watanabe M, Wei F, et al. Bone marrow stromal cells produce long-term pain relief in rat models of persistent pain. Stem Cells. 2011; 29(8): 1294-1303. doi: 10.1002/stem.667</mixed-citation><mixed-citation xml:lang="en">Guo W, Wang H, Zou S, Gu M, Watanabe M, Wei F, et al. Bone marrow stromal cells produce long-term pain relief in rat models of persistent pain. Stem Cells. 2011; 29(8): 1294-1303. doi: 10.1002/stem.667</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Siniscalco D, Giordano C, Galderisi U, Luongo L, de Novellis V, Rossi F, et al. Long-lasting effects of human mesenchymal stem cell systemic administration on pain-like behaviors, cellular, and biomolecular modifications in neuropathic mice. Front Integr Neurosci. 2011; 5: 79. doi: 10.3389/fnint.2011.00079</mixed-citation><mixed-citation xml:lang="en">Siniscalco D, Giordano C, Galderisi U, Luongo L, de Novellis V, Rossi F, et al. Long-lasting effects of human mesenchymal stem cell systemic administration on pain-like behaviors, cellular, and biomolecular modifications in neuropathic mice. Front Integr Neurosci. 2011; 5: 79. doi: 10.3389/fnint.2011.00079</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Naruse K, Sato J, Funakubo M, Hata M, Nakamura N, Kobayashi Y, et al. Transplantation of bone marrow-derived mononuclear cells improves mechanical hyperalgesia, cold allodynia and nerve function in diabetic neuropathy. PLoS One. 2011; 6(11): e27458. doi: 10.1371/journal.pone.0027458</mixed-citation><mixed-citation xml:lang="en">Naruse K, Sato J, Funakubo M, Hata M, Nakamura N, Kobayashi Y, et al. Transplantation of bone marrow-derived mononuclear cells improves mechanical hyperalgesia, cold allodynia and nerve function in diabetic neuropathy. PLoS One. 2011; 6(11): e27458. doi: 10.1371/journal.pone.0027458</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Carey LM, Xu Z, Rajic G, Makriyannis A, Romero J, Hillard C, et al. Peripheral sensory neuron CB2 cannabinoid receptors are necessary for both CB2-mediated antinociceptive efficacy and sparing of morphine tolerance in a mouse model of antiretroviral toxic neuropathy. Pharmacol Res. 2023; 187: 106560. doi: 10.1016/j.phrs.2022.106560</mixed-citation><mixed-citation xml:lang="en">Carey LM, Xu Z, Rajic G, Makriyannis A, Romero J, Hillard C, et al. Peripheral sensory neuron CB2 cannabinoid receptors are necessary for both CB2-mediated antinociceptive efficacy and sparing of morphine tolerance in a mouse model of antiretroviral toxic neuropathy. Pharmacol Res. 2023; 187: 106560. doi: 10.1016/j.phrs.2022.106560</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Rossi F, Bernardo ME, Bellini G, Luongo L, Conforti A, Manzo I, et al. The cannabinoid receptor type 2 as mediator of mesenchymal stromal cell immunosuppressive properties. PLoS One. 2013; 8(11): e80022. doi: 10.1371/journal.pone.0080022</mixed-citation><mixed-citation xml:lang="en">Rossi F, Bernardo ME, Bellini G, Luongo L, Conforti A, Manzo I, et al. The cannabinoid receptor type 2 as mediator of mesenchymal stromal cell immunosuppressive properties. PLoS One. 2013; 8(11): e80022. doi: 10.1371/journal.pone.0080022</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Roche R, Hoareau L, Bes-Houtmann S, Gonthier MP, Laborde C, Baron JF, et al. Presence of the cannabinoid receptors, CB1 and CB2, in human omental and subcutaneous adipocytes. Histochem Cell Biol. 2006; 126(2): 177-187. doi: 10.1007/s00418-005-0127-4</mixed-citation><mixed-citation xml:lang="en">Roche R, Hoareau L, Bes-Houtmann S, Gonthier MP, Laborde C, Baron JF, et al. Presence of the cannabinoid receptors, CB1 and CB2, in human omental and subcutaneous adipocytes. Histochem Cell Biol. 2006; 126(2): 177-187. doi: 10.1007/s00418-005-0127-4</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Xie J, Xiao D, Xu Y, Zhao J, Jiang L, Hu X, et al. Up-regulation of immunomodulatory effects of mouse bone-marrow derived mesenchymal stem cells by tetrahydrocannabinol pre-treatment involving cannabinoid receptor CB2. Oncotarget. 2016; 7(6): 6436-6447. doi: 10.18632/oncotarget.7042</mixed-citation><mixed-citation xml:lang="en">Xie J, Xiao D, Xu Y, Zhao J, Jiang L, Hu X, et al. Up-regulation of immunomodulatory effects of mouse bone-marrow derived mesenchymal stem cells by tetrahydrocannabinol pre-treatment involving cannabinoid receptor CB2. Oncotarget. 2016; 7(6): 6436-6447. doi: 10.18632/oncotarget.7042</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Ruhl T, Karthaus N, Kim BS, Beier JP. The endocannabinoid receptors CB1 and CB2 affect the regenerative potential of adipose tissue MSCs. Exp Cell Res. 2020; 389(1): 111881. doi: 10.1016/j.yexcr.2020.111881</mixed-citation><mixed-citation xml:lang="en">Ruhl T, Karthaus N, Kim BS, Beier JP. The endocannabinoid receptors CB1 and CB2 affect the regenerative potential of adipose tissue MSCs. Exp Cell Res. 2020; 389(1): 111881. doi: 10.1016/j.yexcr.2020.111881</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Василевич И.Б., Пинчук С.В., Лобанок Е.С., Волотовский И.Д. Морфофункциональное состояние мезенхимальных стволовых клеток жировой ткани крыс в условиях подавления окислительного стресса. Весцi Нацыянальнай акадэмii навук Беларусi. Серыя бiялагiчных навук. 2014; (2): 82-88.</mixed-citation><mixed-citation xml:lang="en">Vasilevich IB, Pinchuk SV, Lobanok ES, Volotovski ID. Morphology-function state of rat adipose-derived mesenchymal stem cells under the suppression of oxidative stress. Proceedings of the National Academy of Sciences of Belarus, Medical series. 2014; (2): 82-88. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Deuis JR, Dvorakova LS, Vetter I. Methods used to evaluate pain behaviors in rodents. Front Mol Neurosci. 2017; 10: 284. doi: 10.3389/fnmol.2017.00284</mixed-citation><mixed-citation xml:lang="en">Deuis JR, Dvorakova LS, Vetter I. Methods used to evaluate pain behaviors in rodents. Front Mol Neurosci. 2017; 10: 284. doi: 10.3389/fnmol.2017.00284</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Kappos EA, Sieber PK, Engels PE, Mariolo AV, D’Arpa S, Schaefer DJ, et al. Validity and reliability of the CatWalk system as a static and dynamic gait analysis tool for the assessment of functional nerve recovery in small animal models. Brain Behav. 2017; 7(7): e00723. doi: 10.1002/brb3.723</mixed-citation><mixed-citation xml:lang="en">Kappos EA, Sieber PK, Engels PE, Mariolo AV, D’Arpa S, Schaefer DJ, et al. Validity and reliability of the CatWalk system as a static and dynamic gait analysis tool for the assessment of functional nerve recovery in small animal models. Brain Behav. 2017; 7(7): e00723. doi: 10.1002/brb3.723</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Choi S, Choi HJ, Cheong Y, Lim YJ, Park HK. Internal-specific morphological analysis of sciatic nerve fibers in a radiofrequencyinduced animal neuropathic pain model. PLoS One. 2013; 8(9): e73913. doi: 10.1371/journal.pone.0073913</mixed-citation><mixed-citation xml:lang="en">Choi S, Choi HJ, Cheong Y, Lim YJ, Park HK. Internal-specific morphological analysis of sciatic nerve fibers in a radiofrequencyinduced animal neuropathic pain model. PLoS One. 2013; 8(9): e73913. doi: 10.1371/journal.pone.0073913</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Mert T, Kurt AH, Arslan M, Çelik A, Tugtag B, Akkurt A. Anti-inflammatory and anti-nociceptive actions of systemically or locally treated adipose-derived mesenchymal stem cells in experimental inflammatory model. Inflammation. 2015; 38(3): 1302-1310. doi: 10.1007/s10753-014-0101-1</mixed-citation><mixed-citation xml:lang="en">Mert T, Kurt AH, Arslan M, Çelik A, Tugtag B, Akkurt A. Anti-inflammatory and anti-nociceptive actions of systemically or locally treated adipose-derived mesenchymal stem cells in experimental inflammatory model. Inflammation. 2015; 38(3): 1302-1310. doi: 10.1007/s10753-014-0101-1</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Ruhl T, Corsten C, Beier JP, Kim BS. The immunosuppressive effect of the endocannabinoid system on the inflammatory phenotypes of macrophages and mesenchymal stromal cells: a comparative study. Pharmacol Rep. 2021; 73(1): 143-153. doi: 10.1007/s43440-020-00166-3</mixed-citation><mixed-citation xml:lang="en">Ruhl T, Corsten C, Beier JP, Kim BS. The immunosuppressive effect of the endocannabinoid system on the inflammatory phenotypes of macrophages and mesenchymal stromal cells: a comparative study. Pharmacol Rep. 2021; 73(1): 143-153. doi: 10.1007/s43440-020-00166-3</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
